Skip to main content
. 2016 Jul 9;7(30):46943–46958. doi: 10.18632/oncotarget.10504

Figure 1. Thiacremonone ameliorates MPTP-induced behavior disorder.

Figure 1

Performance on the rotarod is impaired in MPTP injected groups. However, impairment is ameliorated in MPTP-injected thiacremonone treated groups A. MPTP-induced bradykinesia is ameliorated in MPTP-injected thiacremonone treated groups B. Stride length of forelimb C. and hindlimb D. are more increased by thiacremonone treatment in MPTP injection groups. Each value is presented as mean ± SD from 10 mice. *, p < 0.05 Significant difference from saline-injected mice and #, p < 0.05 Significant difference between the MPTP-injection groups.